Titan Pharmaceuticals Inc.
11/14/2025 | Press release | Archived content
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | November 14, 2025 |
| Accession Number: | 0001829126-25-008005 | ||||||
| Submission Type: | POS AM | ||||||
|
|||||||
Titan Pharmaceuticals Inc. published this content on November 14, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on November 17, 2025 at 11:26 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]